| Row | Study Title | Conditions | Interventions | Detail |
|---|---|---|---|---|
| 67 | Pilot Study Assessing the Effect of Cyclin-dependent Kinase 4/6 Inhibitors on Body Composition in Patients With ER+/HER2- Metastatic Breast Cancer | Breast Cancer |
Diagnostic Test:CT scans Diagnostic Test:DEXA scan |
detail |
| 68 | Nivolumab + Cabiralizumab + Gemcitabine Versus Gemcitabine in Patients With Stage IV Pancreatic Cancer Achieving Disease Control in Response to First-line Chemotherapy (GemCaN Trial). | Pancreatic Cancer Stage IV |
Drug:Gemcitabine Drug:Nivolumab 10 MG/ML Intravenous Solution [OPDIVO] Drug:Cabiralizumab |
detail |
| 69 | Define the Optimal Uptake Time of 68Ga-OPS202 When Used as a PET (Positron Emission Tomography) Imaging Agent in Subjects With Newly Diagnosed Breast Cancer | Breast Cancer |
Drug:68Ga-OPS202 |
detail |
| 70 | ACB v FNB for Revision TKA | Revision Total Knee Arthroplasty |
Procedure:Nerve Block for pain control post-revision total knee arthroplasty |
detail |
| 71 | Repeated Muscle Vibration in Acute Stroke | Acute Stroke |
Device:Vibration |
detail |
| 72 | MALIBU Trial - Combination of Ibrutinib and Rituximab in Untreated Marginal Zone Lymphomas | Marginal Zone Lymphoma|Nodal Marginal Zone Lymphoma|Splenic Marginal Zone Lymphoma |
Drug:Ibrutinib Drug:Rituximab |
detail |
| 73 | Effects of Fish Oil in Alleviating Health Hazards Associated With Ozone Exposure | Cardiovascular System|Respiratory System|Oxidative Stress|Inflammation |
Combination Product:fish oil and acute ozone exposure Combination Product:fish oil and sham exposure Combination Product:soy oil and acute ozone exposure Combination Product:soy oil and sham exposure |
detail |
| 76 | Topical INCB018424 Lichen Planus | Lichen Planus |
Drug:INCB018424 |
detail |
| 77 | Endermotherapy With Burn Hypertrophic Scars | Burn Scar |
Procedure:Endermotherapy |
detail |
| 78 | Acceptability of Palliative Care in Parkinson Disease Care | Parkinson Disease |
Behavioral:Palliative Care referral |
detail |
京公网安备 11010102003638号